
-
Trump signs executive order establishing 'Strategic Bitcoin Reserve'
-
Australian casino firm scrambles for cash to survive
-
NYC High Line architect Scofidio dead at 89
-
Musk's SpaceX faces setback with new Starship upper stage loss
-
Australians told 'prepare for worst' as tropical cyclone nears
-
Clark edges two clear at Arnold Palmer Invitational
-
Super cool: ATP sensation Fonseca learning to deal with demands of fame
-
Trump again casts doubt on his commitment to NATO
-
EU leaders agree defence boost as US announces new talks with Kyiv
-
48 killed in 'most violent' Syria unrest since Assad ouster: monitor
-
US and European stocks gyrate on tariffs and growth
-
Deja vu on the Moon: Private US spaceship again lands awkwardly
-
Brazilian teen Fonseca into Indian Wells second round
-
Abortion access under threat in Milei's Argentina
-
Trump backs off Mexico, Canada tariffs after market blowback
-
Trump car tariff pivot and Detroit's 'Big Three'
-
Man Utd draw in Spain in Europa League last 16 as Spurs beaten
-
California's Democratic governor says trans women in sports 'unfair'
-
Trump says Musk should use 'scalpel' not 'hatchet' in govt cuts
-
Goodall, Shatner to receive environmentalist awards from Sierra Club
-
Dingwall glad to be 'the glue' of England's back-line against Italy
-
Chelsea edge Copenhagen in Conference League last 16 first leg
-
Real Sociedad fight back to earn Man United draw in Europa League
-
Chunky canines: Study reveals dog obesity gene shared by humans
-
Europe rallies behind Zelensky as US announces new talks with Kyiv
-
Drop in US border crossings goes deeper than Trump
-
Guyana appeals to UN court as Venezuelan plans vote in disputed zone
-
Private US spaceship lands near Moon's south pole in uncertain condition
-
Saudi PIF to pay 'up to 12 months maternity leave' for tennis players
-
16 killed in 'most violent' Syria unrest since Assad ouster: monitor
-
Peru farmer confident ahead of German court battle with energy giant
-
US-Hamas talks complicate Gaza truce efforts: analysts
-
European rocket successfully carries out first commercial mission
-
SpaceX gears up for Starship launch as Musk controversy swirls
-
Trump backs off Mexico tariffs while Canada tensions simmer
-
Europe's new rocket blasts off on first commercial mission
-
SpaceX gearing up for Starship launch amid Musk controversy
-
Racked by violence, Haiti faces 'humanitarian catastrophe': MSF
-
Gisele Pelicot's daughter says has filed sex abuse case against father
-
New Zealand set for 'scrap' with India on slower pitch: Santner
-
US signals broader tariff reprieve for Canada, Mexico as trade gap grows
-
US to carry out first firing squad execution since 2010
-
Roy Ayers, godfather of neo-soul, dead at 84
-
ECB chief warns of 'risks all over' as rates cut again
-
Albania to shut down TikTok in coming days
-
Pompidou museum invites public for last look before renovation
-
Graham returns for Scotland's Six Nations match against Wales
-
US firm hours away from Moon landing with drill, rovers, drone
-
Bosnian Serb leader rejects prosecutor summons as crisis deepens
-
England considering Test skipper Stokes for white-ball captaincy

Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
O.Lorenz--BTB